Genome research centre established in Shanghai:
This article was originally published in Clinica
Executive Summary
A human genome research centre has been set up in Shanghai to identify the genetic causes of disease and examine genomic structure and function. The centre is part of the China National Centre for Bioengineering Development and the Shanghai Science and Technology Commission. Universities, medical facilities and other Shanghai-based research institutes will be involved in the centre, which will initially focus on diseases of particular relevance to China, such as liver disorders, leukaemia, diabetes and cardiovascular disease, reports the Xinhua news agency.
You may also be interested in...
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.
Medtronic Launches Remote Live-Stream Surgery, New AI Capabilities
Medtronic will launch a new feature that allows for live streaming of surgical procedures in more than 20 countries and the addition of 14 AI-driven algorithms to enhance surgical workflow.
News We’re Watching: AI Safety Partnership; Boston Scientific Recalls; New Cancer, STI Tests; VR
This week, the US and UK announced a partnership to promote AI safety. Boston Scientific recalls embolic agent. LumiCell received FDA approval for its imaging agent to detect residual cancer. Scout receives an award to develop an STI test; and Osso VR leverages the Apple Vision Pro for VR medical training.